GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » SD Biotechnologies Co Ltd (XKRX:217480) » Definitions » Debt-to-Equity

SD Biotechnologies Co (XKRX:217480) Debt-to-Equity : 0.54 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is SD Biotechnologies Co Debt-to-Equity?

SD Biotechnologies Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩23,590 Mil. SD Biotechnologies Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩94 Mil. SD Biotechnologies Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩44,005 Mil. SD Biotechnologies Co's debt to equity for the quarter that ended in Dec. 2023 was 0.54.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for SD Biotechnologies Co's Debt-to-Equity or its related term are showing as below:

XKRX:217480' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03   Med: 0.25   Max: 19.11
Current: 0.54

During the past 10 years, the highest Debt-to-Equity Ratio of SD Biotechnologies Co was 19.11. The lowest was 0.03. And the median was 0.25.

XKRX:217480's Debt-to-Equity is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.41 vs XKRX:217480: 0.54

SD Biotechnologies Co Debt-to-Equity Historical Data

The historical data trend for SD Biotechnologies Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SD Biotechnologies Co Debt-to-Equity Chart

SD Biotechnologies Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.43 1.52 19.11 0.54

SD Biotechnologies Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.11 3.42 3.92 4.72 0.54

Competitive Comparison of SD Biotechnologies Co's Debt-to-Equity

For the Household & Personal Products subindustry, SD Biotechnologies Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SD Biotechnologies Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, SD Biotechnologies Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where SD Biotechnologies Co's Debt-to-Equity falls into.



SD Biotechnologies Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

SD Biotechnologies Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

SD Biotechnologies Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SD Biotechnologies Co  (XKRX:217480) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


SD Biotechnologies Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of SD Biotechnologies Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SD Biotechnologies Co (XKRX:217480) Business Description

Traded in Other Exchanges
N/A
Address
Airport Expressway 61 Road 29 C-301, Gangseo-gu, Seoul, KOR, 07563
SD Biotechnologies Co Ltd develops and manufactures cosmetics. The company offers face masks and skin care products. It offers ampoule masks, tone-up sun products, hydra lifting masks, Lip Rouge and Lip Tint products, liquid eye tints, and glow products under the SNP, Seoul café, and celebeau brands, as well as oil and drying defender products, foam and shave cleansers, and guy brow products for men under the M'SOLIC brand.

SD Biotechnologies Co (XKRX:217480) Headlines

No Headlines